MIRA INFORM REPORT

 

 

Report No. :

298088

Report Date :

27.01.2015

 

IDENTIFICATION DETAILS

 

Name :

PRACHI PHARMACEUTICALS PRIVATE LIMITED

 

 

Registered Office :

8-Ebrahim Rahimtoola Rdprincess Bldg, Near J.J. Hospital, Mumbai - 400003, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

13.07.1987

 

 

Com. Reg. No.:

11-044050

 

 

Capital Investment / Paid-up Capital :

Rs. 20.000 Millions

 

 

CIN No.:

[Company Identification No.]

U24230MH1987PTC044050

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMP19918D

 

 

PAN No.:

[Permanent Account No.]

AAACP7440A

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of active Pharmaceutical Ingredients, Iodine Compounds Veterinary Products and Specialty Chemicals.

 

 

No. of Employees :

100 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (47)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 92000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record.

 

Overall financial position of the company is decent.

 

Trade relations are reported to be fair. Business is active. Payments are reported to be usually correct.

 

The company can be considered for business dealing at usual trade terms and conditions. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2014

 

Country Name

Previous Rating

(30.06.2014)

Current Rating

(30.09.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Pankaj Shah

Designation :

Director

Contact No.:

91-9323420671

Date :

08.01.2015

 

 

LOCATIONS

 

Registered Office :

8-Ebrahim Rahimtoola Rdprincess Bldg, Near J.J. Hospital, Mumbai - 400003, Maharashtra, India

Tel. No.:

91-22-24131362

Mobile No.:

91-9323420671 (Mr. Pankaj Shah)

Fax No.:

91-22-23778597/24130877

E-Mail :

prachiint@vanl.com

prachiint@bom.7.vsnl.net.in

Website :

http://www.activepharmaingredients.com

http://www.prachipharma.com 

Area :

250 Sq. Ft.

Location :

Owned

 

 

Corporate Office :

11/1, Rakhangi Mahal, Acharya Donde Marg, Opposite Wadia Children Hospital, Parel, Mumbai - 400 012, Maharashtra, India

Tel. No.:

91-22-24165274

Fax No.:

91-22-24130877

E-Mail :

prachiint@bom7.vsnl.net.in

prachint@vsnl.com

Area :

Owned

Location :

300 Sq. Ft.

 

 

Factory :

E-108, MIDC, Tarapur, Boisar – 401 502, District Thane, Maharashtra, India

Tel No. :

91-252-270920

Area :

Owned

Location :

1 acre

 

 

DIRECTORS

 

As on 31.03.2013

 

Name :

Mr. Pankaj Talakshi Shah

Designation :

Director

Address :

B / 201, Sorento Co-operative Housing Society, Shanti Park, Ghatkopar [East], Mumbai – 400077, Maharashtra, India

Date of Birth/Age :

16.06.1956

Qualification :

Bsc., B. Tech (Pharmaceutical)

Date of Appointment :

13.07.1987

DIN No.:

01089539

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230MH1987PTC044050

PRACHI PHARMACEUTICALS PRIVATE LIMITED

Director

13-07-1987

13-07-1987

-

Active

NO

2

U24110MH1991PTC064500

MALDIP CHEMICALS P.LTD.

Director

17-12-1991

17-12-1991

-

Active

NO

 

 

Name :

Mr. Chintan Pankaj Shah

Designation :

Director

Address :

B / 201, Sorento Co-operative Housing Society, Shanti Park, Ghatkopar [East], Mumbai – 400077, Maharashtra, India

Date of Appointment :

10.03.2008

DIN No.:

02053745

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 31.03.2013

 

Names of Shareholders

 

No. of Shares

Pankaj Talakshi Shah

 

999997

Malti Pankaj Shah

 

919996

Chintan Pankaj Shah

 

50000

Shali Pankaj Shah

 

30000

Savitaben C Shah

 

2

Rajendra Shah

 

1

Padamshi S Shah

 

1

National Book Depot, Mumbai

 

1

Hirachand S Shah

 

1

Maldip Chemicals Private Limited, Mumbai 

 

1

Total

 

2000000

 

Equity Share Break up (Percentage of Total Equity)

 

As on 31.03.2013

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of active Pharmaceutical Ingredients, Iodine Compounds Veterinary Products and Specialty Chemicals.

 

 

Products :

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

Not Divulged

 

 

Exports :

 

Products :

Active Pharmaceutical Ingredients

Countries :

  • UAE
  • Germany
  • Spain
  • Australia
  • UK
  • China
  • USA
  • France
  • European Countries

 

 

Imports :

 

Products :

Raw Material

Countries :

  • China
  • Japan
  • Indonesia
  • Turkey
  • Middle East

 

 

Terms :

 

Selling :

Cash and Credit (60 Days)

 

 

Purchasing :

Cash and Credit (60 Days)

 

 

PRODUCTION STATUS NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Kantilal Maniklal and Company

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

Customers :

Reference :

Hetero Drugs Limited

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

No. of Employees :

100 (Approximately)

 

 

Bankers :

  • Bombay Mercantile Co-operative Bank Limited, E R Road Branch, Mumbai – 400003, Maharashtra, India
  • Tata Capital Financial Services Limited, One Forbes, Dr. V. B. Gandhi Marg, Fort Mumbai – 400001, Maharashtra, India

 

 

Facilities :

Secured Loan

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

Long-term Borrowings

 

 

BMC Term Loan A/c: 3001/52

(Secured against Hypothecation of inventories

Book Debts, Mortgage of Immovable &

Movable Properties Of the Company &

Guaranteed by Directors)

1.995

1.925

DCK

3.458

3.458

 

Kotak Mahindra Primus Limited

0.497

0.000

Short-term borrowings

 

 

Cash Credit A/c

Bombay Mercantile Co-op Bank 

34.176

34.712

A/C no. OD/HP -16015

Rupee Loan

4.377

0.000

Total

44.503

40.095

 

Auditors :

 

Name :

P. J. Raichura and Company

Chartered Accountants

Address :

71/72 Ashok Chambers, Devji Ratanshi Marg, Masjid Bunder, Mumbai – 400 009, India

Tel. No.:

91-22-66314319

Fax No.:

91-22-23480069

E-Mail :

pjraichura@gmail.com

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Parties where control exists and Related party Relationships where transaction have taken place during the year :

  • Maldip Chemicals Private Limited

 

 

CAPITAL STRUCTURE

 

As on 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2000000

Equity Shares

Rs.10/- each

Rs.20.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2000000

Equity Shares

Rs.10/- each

Rs.20.000 Millions

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2013

31.03.2012

31.03.2011

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

20.000

20.000

20.000

(b) Reserves & Surplus

12.095

6.955

5.799

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

32.095

26.955

25.799

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

18.078

17.856

16.763

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

18.078

17.856

16.763

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

38.553

34.711

34.941

(b) Trade payables

74.267

38.490

27.168

(c) Other current liabilities

1.005

1.434

1.554

(d) Short-term provisions

0.000

0.000

0.000

Total Current Liabilities (4)

113.825

74.635

63.663

 

 

 

 

TOTAL

163.998

119.446

106.225

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

42.370

40.686

37.890

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

1.370

1.310

1.280

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

43.740

41.996

39.170

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

61.544

23.664

28.625

(c) Trade receivables

27.093

39.715

23.589

(d) Cash and cash equivalents

22.505

10.488

11.950

(e) Short-term loans and advances

0.000

0.000

0.000

(f) Other current assets

9.116

3.583

2.891

Total Current Assets

120.258

77.450

67.055

 

 

 

 

TOTAL

163.998

119.446

106.225

 

 

PROFIT & LOSS ACCOUNT

 

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

Income

207.794

98.399

78.007

 

Other Income

1.257

0.323

0.000

 

TOTAL (A)

209.051

98.722

78.007

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

192.964

79.121

0.000

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(15.629)

(5.629)

0.000

 

Employees benefits expense

8.306

6.616

0.000

 

Selling & Distribution Expenses

9.252

8.960

0.000

 

TOTAL (B)

194.893

89.068

67.964

 

 

 

 

 

Less

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (C)

14.157

9.654

10.043

 

 

 

 

 

Less

FINANCIAL EXPENSES (D)

7.132

6.698

6.228

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E)

7.025

2.956

3.815

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION (F)

1.886

1.799

2.384

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX (E-F)   (G)

5.139

1.157

1.431

 

 

 

 

 

Less

TAX (I)

0.000

0.000

0.280

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX  (G-I)   (J)

5.139

1.157

1.151

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD  (K)

5.821

4.664

3.513

 

 

 

 

 

Add

Earlier year excess proposed dividend and dividend distribution tax (L)

0.000

0.000

0.000

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

Transfer to General Reserve

(1.134)

(1.134)

0.000

 

Dividend

 

 

 

 

Tax on Dividend

 

 

 

 

Total (M)

(1.134)

(1.134)

0.000

 

 

 

 

 

 

Balance Carried to the B/S (J+K+L-M)

12.094

6.955

4.664

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

 

 

 

 

Basic

2.57

0.58

 0.00

 

Diluted

2.57

0.58

 0.00

 

 

Particulars

 

 

 

31.03.2014

Sales Turnover (Approximately)

 

 

300.000

 

Expected Sales (2014 - 2015): Rs. 400.000 Millions.

 

The above information has been parted by Mr. Pankaj Shah (Director).

 

 

KEY RATIOS

 

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

Net Profit Margin

(PAT / Sales)

(%)

2.47

1.18

1.48

 

 

 

 

 

Operating Profit Margin

(PBIDT/Sales)

(%)

6.81

9.81

12.87

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

3.16

0.98

1.36

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.16

0.04

0.06

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

1.76

1.95

2.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.06

1.04

1.05

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

20.000

20.000

20.000

Reserves & Surplus

5.799

6.955

12.095

Net worth

25.799

26.955

32.095

 

 

 

 

long-term borrowings

16.763

17.856

18.078

Short term borrowings

34.941

34.711

38.553

Total borrowings

51.704

52.567

56.631

Debt/Equity ratio

2.004

1.950

1.764

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

78.007

98.399

207.794

 

 

26.141

111.175

 

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

78.007

98.399

207.794

Profit

1.151

1.157

5.139

 

1.48%

1.18%

2.47%

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

Yes

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

Yes

18]

Major customers

Yes

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

No

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

INDEX OF CHARGES

 

No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10508451

16/12/2014 *

106,500,000.00

The Shamrao Vithal Co-operative Bank Ltd.

Unit 1 & 2, Ground Floor, Aalap CHS Ltd, Sir Bhal
chandra Road, Hindu Colony, Dadar (E), Mumbai, Mah
arashtra - 400014, INDIA

C38760310

2

10488400

08/07/2014 *

46,500,000.00

The Shamrao Vithal Co-operative Bank Ltd.

Unit 1 & 2, Ground Floor, Aalap CHS Ltd, Sir Bhal
chandra Road, Hindu Colony, Dadar (E), Mumbai, Mah
arashtra - 400014, INDIA

C14062418

3

10477805

30/01/2014

6,600,000.00

TATA CAPITAL FINANCIAL SERVICES LIMITED

One Forbes,, Dr. V. B. Gandhi Marg, Fort, Mumbai,
Maharashtra - 400001, INDIA

B96452768

4

10313070

10/09/2011

3,000,000.00

Bombay Mercantile Co-operative Bank Ltd

E R Road Branch,, 132-134, Ebrahim Rehimtoola Roa
d,, Mumbai, Maharashtra - 400003, INDIA

B23510647

5

10045730

09/04/2007

25,000,000.00

BOMBAY MERCANTILE CO-OP BANK LTD E. R ROAD BRANCH

E. R ROAD, MUMBAI, Maharashtra - 400003, INDIA

A13388962

6

90225360

09/08/2004

5,000,000.00

BOMBAY MERCANTILE CO-OPRATIVE BANK LIMITED

MOHMEDALI ROAD, BOMBAY, Maharashtra, INDIA

-

7

90225304

16/01/2004

10,000,000.00

BOMBAY MERCANTILE CO-OPRATIVE BANK LIMITED

MOHMEDALI ROAD, BOMBAY, Maharashtra, INDIA

-

8

90225297

03/12/2003

3,000,000.00

BOMBAY MERCANTILE CO-OPRATIVE BANK LIMITED

MOHMEDALI ROAD, BOMBAY, Maharashtra, INDIA

-

9

90225293

26/09/2012 *

27,500,000.00

BOMBAY MERCANTILE CO-OPERATIVE BANK LIMITED

Navratna Bldg., P.D'Mello Road,, Carnac Bunder,,
Mumbai, Maharashtra - 400009, INDIA

B62900329

10

90225235

31/01/2003

25,000,000.00

BOMBAY MERCANTILE CO-OPRATIVE BANK LIMITED

MOHMEDALI ROAD, BOMBAY, Maharashtra, INDIA

-

 

 

UNSECURED LOAN

 

PARTICULARS

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

Long-term Borrowings

 

 

Loan From Directors & Relatives

 

 

Pankaj T. Shah

1.172

0.834

Rajendra P. Shah

1.155

1.165

Padamshi S. Shah

0.133

0.134

Chintan P. Shah

1.100

0.764

Shaili P. Shah

0.388

0.390

Malti P Shah

0.127

0.127

National Book Depot

1.302

1.302

Maldip Chemicals Pvt Ltd

2.568

2.590

Loan from Others

 

 

Hirachand S. Shah

0.032

0.031

Savitaben C. Shah

4.151

5.135

Total

12.128

12.472

 

 

FIXED ASSETS

 

  • Leasehold Land
  • Factory Building
  • Plant and Machinery
  • Electric Installation
  • Office Equipment’s
  • Furniture and Fixtures
  • Computers
  • Cylinder Purchase
  • Motor Car
  • Air Conditioners
  • Fire Extinguisher
  • Lift
  • Telephone
  • Lab Instruments
  • Standard weights

 

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.50

UK Pound

1

Rs.92.16

Euro

1

Rs.69.62

 

 

INFORMATION DETAILS

 

Information Gathered by :

PAT

 

 

Analysis Done by :

SUM

 

 

Report Prepared by :

RCH


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILITY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

---

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

47

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.